REGENERON PHARMACEUTICALS INC 4
4 · REGENERON PHARMACEUTICALS INC · Filed Sep 18, 2015
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Sale
Common Stock
2015-09-17$550.00/sh−5,000$2,750,000→ 9,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-09-17−5,000→ 5,000 totalExercise: $18.61Exp: 2019-01-02→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-09-17$18.61/sh+5,000$93,050→ 14,000 total
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.